Fresh Top Buy Recommendations for March 9

Top Five Stocks Upgraded to Zacks Rank #1 (Strong Buy)

Today, five companies have been newly recognized as Zacks Rank #1 (Strong Buy) stocks. Here’s a closer look at each:

• Everus Construction Group, Inc. (ECG): This provider of contracting services has experienced a 9.8% rise in its current year earnings estimate from Zacks Consensus over the past two months.

  Everus Construction Group, Inc.: Price and Analyst Consensus

• Amneal Pharmaceuticals, Inc. (AMRX): This international biopharmaceutical firm has seen its Zacks Consensus Estimate for annual earnings climb by 6.4% in the last 60 days.

  Amneal Pharmaceuticals, Inc.: Price and Analyst Consensus

• National Energy Services Reunited Corp. (NESR): This oilfield services provider has had its current year earnings estimate from Zacks Consensus increase by 7.4% over the last two months.

  National Energy Services Reunited: Price and Analyst Consensus

• ACM Research, Inc. (ACMR): This capital equipment manufacturer’s current year earnings estimate has jumped 13.3% in the last 60 days, according to Zacks Consensus.

  ACM Research, Inc.: Price and Analyst Consensus

• The Hershey Company (HSY): This well-known producer of confectionery and pantry staples has seen its Zacks Consensus Estimate for annual earnings surge by 18.1% over the last two months.

  The Hershey Company: Price and Analyst Consensus

Five Stocks Poised for Significant Growth

Each of these stocks has been selected by a Zacks analyst as their top pick with the potential to double in value over the next year. While not every recommendation achieves such gains, past selections have delivered returns of +112%, +171%, +209%, and even +232%.

Many of these companies remain largely unnoticed by major Wall Street players, offering investors a unique chance to invest early.

• The Hershey Company (HSY): Complimentary Stock Analysis
• ACM Research, Inc. (ACMR): Complimentary Stock Analysis
• National Energy Services Reunited (NESR): Complimentary Stock Analysis
• Amneal Pharmaceuticals, Inc. (AMRX): Complimentary Stock Analysis
• Everus Construction Group, Inc. (ECG): Complimentary Stock Analysis

Originally published by Zacks Investment Research.

For more information, visit Zacks Investment Research.